trimethoprim- trimethoprim tablet
pd-rx pharmaceuticals, inc. - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - trimethoprim 100 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of trimethoprim tablets, usp and other antibacterial drugs, trimethoprim tablets, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. for the treatment of initial episodes of uncomplicated urinary tract infections due to susceptible strains of the following organisms: escherichia coli , proteus mirabilis , klebsiella pneumoniae , enterobacter species, and coagulase-negative staphylococcus species, including s. saprophyticus . cultures and susceptibility tests should be performed to determine the susceptibility of the bacteria to trimethoprim. therapy may be initiated prior to obtaining the
intertrim-480 oral suspenion oral
interchemie werken 'de adelaar' b.v. - trimethoprim, sulfadiazine - suspenion oral - 80mg/ml+ 400mg/ml
trisoprim antibacterial tablet
troy laboratories pty ltd - trimethoprim; sulfadiazine - oral tablet - trimethoprim pyrimidine active 80.0 mg/tb; sulfadiazine sulfanyl active 400.0 mg/tb - antibiotic & related - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - bacterial infection | organisms sensitive to combination of | topical infection | amoxycillin sensitive bacteria | associated with viral disease | gram negative organisms | gram positive organisms | post parturient bacterial infe | primary bacterial infection | sulfadiazine sensitive bacteri | trimethoprim sensitive bacteri | tylosin sensitive bacteria
trimethoprim- trimethoprim tablet
watson labs - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - tablet - 100 mg - for the treatment of initial episodes of uncomplicated urinary tract infections due to susceptible strains of the following organisms: escherichia coli, proteus mirabilis, klebsiella pneumoniae, enterobacter species and coagulase-negative staphylococcus species, including s. saprophyticus. cultures and susceptibility tests should be performed to determine the susceptibility of the bacteria to trimethoprim. therapy may be initiated prior to obtaining the results of these tests. trimethoprim tablets are contraindicated in individuals hypersensitive to trimethoprim and in those with documented megaloblastic anemia due to folate deficiency.
trimethoprim tablet
carilion materials management - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - trimethoprim 100 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of trimethoprim tablets, usp and other antibacterial drugs, trimethoprim tablets, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. for the treatment of initial episodes of uncomplicated urinary tract infections due to susceptible strains of the following organisms: escherichia coli , proteus mirabilis , klebsiella pneumoniae , enterobacter species, and coagulase-negative staphylococcus species, including s. saprophyticus . cultures and susceptibility tests should be performed to determine the susceptibility of the bacteria to trimethoprim. therapy may be initiated prior to obtaining the
sulfadiazine 500mg tablets bp
wockhardt uk limited ash road north, wrexham, ll13 9uf, united kingdom - sulfadiazine - tablet - sulfadiazine 500 mg - antibacterials for systemic use
trimethoprim 200mg tablets
milpharm limited - trimethoprim - tablets - 200mg - systemic antibacterial - treatment of susceptible infections caused by trimethoprim sensitive organisms including most gram-positive and gram-negative aerobic organisms, including haemophilus influenzae, streptococcus pneumoniae, klebsiella pneumonia, staphylococcus aureus, eschersichia coli, enterobacter, proteus and streptococcus faecalis. exceptions include anaerobic bacteria. mycobacterium tuberculosis, neisseria gonorrhoeae, pseudomonas aeruginosa and treponema pallidum. prophylaxis of recurrent urinary tract infections. consideration should be given to official guidance on the appropriate use of antibacterial agents
trimethoprim 100mg tablets
milpharm limited - trimethoprim - tablets - 100mg - treatment of susceptible infections caused by trimethoprim sensitive organisms including most gram-positive and gram-negative aerobic organisms, including haemophilus influenzae, streptococcus pneumoniae, klebsiella pneumonia, staphylococcus aureus, eschersichia coli, enterobacter, proteus and streptococcus faecalis. exceptions include anaerobic bacteria. mycobacterium tuberculosis, neisseria gonorrhoeae, pseudomonas aeruginosa and treponema pallidum. prophylaxis of recurrent urinary tract infections. consideration should be given to official guidance on the appropriate use of antibacterial agents
trimoxine-48 80 mg/ 400 mg per ml solution for injection (im)
p & d medivet distribution, inc.; distributor: p & d medivet distribution, inc. - trimethoprim , sulfadiazine (vet.) - solution for injection (im) - 80 mg/ 400 mg per ml
vr tridiazine oral paste
jurox pty limited - trimethoprim; sulfadiazine - oral paste - trimethoprim pyrimidine active 67.0 mg/g; sulfadiazine sulfanyl active 333.0 mg/g - antibiotic & related - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - bacterial disease